Trial Profile
A phase I trial to evaluate multiple fixed‑dose combinations of Gemcabene with atorvastatin.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 20 Apr 2017
Price :
$35
*
At a glance
- Drugs Gemcabene (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia; Hypertension; Hypertriglyceridaemia; Non-alcoholic steatohepatitis; Osteoarthritis
- Focus Adverse reactions; Pharmacokinetics
- 20 Apr 2017 New trial record